ONL Therapeutics' Debt - II Round

ONL Therapeutics raised a round of funding on September 21, 2018.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. Existing therapies have significant limitations and none address the initial ne…

Articles about ONL Therapeutics' Debt - II Round: